Security key
15117F500
Cellectar Biosciences, Inc. - Common Stock (CLRB)
CUSIP: 15117F500
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,719,970
- Total 13F shares
- 4,743,321
- Share change
- -1,607,787
- Total reported value
- $1,914,000
- Price per share
- $0.40
- Number of holders
- 24
- Value change
- -$711,862
- Number of buys
- 8
- Number of sells
- 10
Report period
Q2 2022
Institutions
24
Top holders
10
CLRB full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F500
Recent filing periods:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
|
Company |
21%
|
1,837,046
|
$1,263,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
20%
|
1,753,800
|
$1,206,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.2%
|
712,679
|
$489,000 | — | 31 Mar 2022 | |
| Worth Venture Partners, LLC |
13F
|
Company |
5.3%
|
458,245
|
$315,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.1%
|
441,883
|
$303,000 | — | 31 Mar 2022 | |
| Maven Securities LTD |
13F
|
Company |
4.6%
|
400,000
|
$275,000 | — | 31 Mar 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
217,500
|
$150,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
150,346
|
$103,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
142,400
|
$98,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
126,800
|
$87,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
121,738
|
$84,000 | — | 31 Mar 2022 | |
| 1900 WEALTH MANAGEMENT LLC |
13F
|
Company |
1.4%
|
120,000
|
$83,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
95,438
|
$66,000 | — | 31 Mar 2022 | |
| COZAD ASSET MANAGEMENT INC |
13F
|
Company |
0.64%
|
56,000
|
$39,000 | — | 31 Mar 2022 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.42%
|
36,799
|
$25,000 | — | 31 Mar 2022 | |
| Sterneck Capital Management, LLC |
13F
|
Company |
0.34%
|
30,000
|
$21,000 | — | 31 Mar 2022 | |
| Modera Wealth Management, LLC |
13F
|
Company |
0.23%
|
20,000
|
$14,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
16,500
|
$11,000 | — | 31 Mar 2022 | |
| COMMERCE BANK |
13F
|
Company |
0.16%
|
14,280
|
$10,000 | — | 31 Mar 2022 | |
| Prospera Financial Services Inc |
13F
|
Company |
0.16%
|
13,754
|
$9,000 | — | 31 Mar 2022 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.13%
|
11,631
|
$8,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
10,700
|
$7,000 | — | 31 Mar 2022 | |
| DIFESA CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.11%
|
10,000
|
$7,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.1%
|
8,457
|
$6,000 | — | 31 Mar 2022 | |
| Johnson Financial Group, Inc. |
13F
|
Company |
0.06%
|
5,500
|
$4,000 | — | 31 Mar 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.06%
|
5,000
|
$3,000 | — | 31 Mar 2022 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
2,857
|
$2,000 | — | 31 Mar 2022 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.02%
|
2,000
|
$1,000 | — | 31 Mar 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
5
|
$1,000 | — | 31 Mar 2022 | |
| Dov Elefant |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
422,000
|
— | — | 25 Jan 2022 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock (CLRB) as of Q2 2022
As of 30 Jun 2022,
Cellectar Biosciences, Inc. - Common Stock (CLRB) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,743,321 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., AIGH Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, Maven Securities LTD, ACT CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Bank of New York Mellon Corp, and FRANKLIN RESOURCES INC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
27
Q2 2022 holders
24
Holder diff
-3
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.